Home
Conditions
Neuroectodermal Tumors, Primitive, Peripheral

Clinical trial condition

Neuroectodermal Tumors, Primitive, Peripheral

Explore clinical trials studying Neuroectodermal Tumors, Primitive, Peripheral. Study availability and eligibility vary by location and protocol.

501 public trials 99 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive, Peripheral trial results

Completed

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

NCT01132911

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Tabectedin to Treat Children and Adolescents With Cancer

NCT01453283

Conditions: Adenocarcinoma, Brain Diseases, Brain Neoplasms, +45 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

NCT00795769

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

NCT00806182

Conditions: Ataxia, Autoimmune Diseases, Central Nervous System Diseases, +27 more
Locations: National Pediatric Myoclonus Center, Formerly at Dept. of Neurology, Southern Illinois University School of Medicine Springfield, Illinois, United States

View Trial Details

Completed

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

NCT01288573

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumors, +16 more
Locations: Investigational Site Number 51 Ghent, Belgium

Investigational Site Number 81 Brno, Czechia

Investigational Site Number 82 Praha 5 - Motol, Czechia

Investigational Site Number 61 København Ø, Denmark

View all 27 locations

View Trial Details

Completed

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

NCT00509691

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

NCT01241162

Conditions: Disease Attributes, Ewings Sarcoma, Myosarcoma, +24 more
Locations: University of Louisville, Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States

View Trial Details

Completed

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

NCT00248547

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

NCT01125800

Conditions: Astrocytoma, Disease Attributes, Glioma, +21 more
Locations: Children's Healthcare of Atlanta Childern Hosp - ATL Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins Baltimore, Maryland, United States

Dana Farber Cancer Institute DFCI (3) Boston, Massachusetts, United States

Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States

View all 14 locations

View Trial Details

Completed

Surgery in Treating Children With Neuroblastoma

NCT00003119

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

University of South Alabama Cancer Research Institute Mobile, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

View all 235 locations

View Trial Details

Neuroectodermal Tumors, Primitive, Peripheral

Neuroectodermal Tumors, Primitive, Peripheral trial results

Related conditions